Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1

• Κύριοι συγγραφείς: Huanhuan Hou (Συγγραφέας), Qisheng Peng (Συγγραφέας), Shaoming Wang (Συγγραφέας), Yuxin Zhang (Συγγραφέας), Jinjin Cao (Συγγραφέας), Yuming Deng (Συγγραφέας), Yingjian Wang (Συγγραφέας), Wan-chun Sun (Συγγραφέας), Hong-bing Wang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Osteoporosis is a metabolic bone disease characterized by insufficient osteoblastic function and/or excessive osteoclastic activity. One promising strategy for treating osteoporosis is inhibiting excessive osteoclast resorbing activity. Previous studies have revealed that anemonin (ANE), isolated fr...